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Abstract
A novel open tubular nanoproteomic platform featuring accelerated on-line protein digestion and high-resolution nano
liquid chromatography mass spectrometry (LC-MS) has been developed. The platform features very narrow open tubular
columns, and is hence particularly suited for limited sample amounts. For enzymatic digestion of proteins, samples are
passed through a 20 mm inner diameter (ID) trypsin + endoproteinase Lys-C immobilized open tubular enzyme reactor
(OTER). Resulting peptides are subsequently trapped on a monolithic pre-column and transferred on-line to a 10 mm ID
porous layer open tubular (PLOT) liquid chromatography LC separation column. Wnt/ß-catenein signaling pathway (Wnt-
pathway) proteins of potentially diagnostic value were digested+detected in targeted-MS/MS mode in small cell samples
and tumor tissues within 120 minutes. For example, a potential biomarker Axin1 was identifiable in just 10 ng of sample
(protein extract of ,1,000 HCT15 colon cancer cells). In comprehensive mode, the current OTER-PLOT set-up could be used
to identify approximately 1500 proteins in HCT15 cells using a relatively short digestion+detection cycle (240 minutes),
outperforming previously reported on-line digestion/separation systems. The platform is fully automated utilizing common
commercial instrumentation and parts, while the reactor and columns are simple to produce and have low carry-over. These
initial results point to automated solutions for fast and very sensitive MS based proteomics, especially for samples of limited
size.
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Introduction
As cancer medicine evolves towards personalized treatment, the
need for high throughput, selective and sensitive methods for
monitoring key diagnostic-value biomolecules is increasing [1–3].
In this regard, much diagnosis-relevant sample measurements are
expected to be performed at the gene/mRNA level, and several
high-throughput genetic testing methods have been developed for
e.g. breast, colon, prostate and colorectal cancer [4–7]. Still,
changes in the gene expression might not be reflected on the level
of protein expression or function [8,9]. Measuring proteins is
therefore important for understanding the link between gene, gene
variants and their contribution to the pathology of disease [10].
Although protein identification/measurement with e.g. Western
Blotting (WB) has been predicted to have an increasingly larger
role in clinics, WB has several disadvantages, e.g. limited numbers
of analytes per test and selectivity issues [11].
MS based approaches can provide additional information with
higher throughput, selectivity or sensitivity compared to e.g. WB,
ELISA, DNA and mRNA sequencing [11–14]. However,
standard protein MS methodologies can be very slow; cleaving
proteins into MS-friendly peptides can demand overnight treat-
ment (typically performed with the enzymes trypsin and/or Lys-
C), and comprehensive LC-electrospray ionization (ESI) MS
processes can take tens of hours [15–24]. The lengthy LC-MS
processing is much related to the inability of standard LC to
sufficiently separate all of the peptides in a mixture (which can be
hundreds of thousands), that in turn compromises the ESI step (i.e.
co-eluting peptides suppressing the signal of one another).
Therefore, a goal in the LC-MS based proteomics is to develop
novel LC columns/materials that provide improved separation,
i.e. high peak capacity; contemporary approaches include
development of monolithic materials (silica and organic [25,26]),
ultra high performance LC (UHPLC) [27] and fused core particle
materials [28].
The rate-limiting step of the enzymatic cleaving of proteins is
the use of relatively slow in-solution procedures. Thus, another
goal is to develop procedures that accelerate the enzyme reaction
step: one approach is the use of immobilized enzyme reactors
(IMERs), as they have several advantages compared to standard
in-solution/in-gel approaches, such as larger enzyme to substrate
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ratio, higher digestion efficiency, long-term stability and reusability
[29,30].
For improving both LC separation and accelerate enzymatic
digestion, we have recently demonstrated the proof of principle of
using a (manually operated) ‘‘lab-on-a column’’ system with open
tubular columns (instead of particle packed/polymer-filled col-
umns used nearly invariably in today’s LC laboratories). Specif-
ically, trypsin was immobilized on to 20 mm ID polymer-wall
coated capillaries (OTERs), cleaving an isolated small cell lung
cancer (SCLC) marker (ProGRP) into peptides that were
subsequently separated by high peak capacity PLOT LC columns
(10 mm ID [31]), with cleavage and LC-MS run time of totally 40
minutes.
Although known to be a path to ultra-high resolution and
sensitivity, PLOT columns have hardly been used in LC-MS
(notable exceptions are described in references [31–36]) much due
to incompatibilities with commercial LC instrumentation and
detectors. These issues are to a large degree resolved [31,35]. In
addition to high LC performance, PLOT columns are simple to
manufacture, with a high degree of reproducibility [34,36].
We here describe a further developed OTER-PLOT system
that enables fast enzyme cleavage and selective detection of target
proteins in biological samples. The OTERs have been improved
by e.g. increasing reactor length (volume) and immobilizing with a
combination of trypsin and Lys-C, and the system is now fully
automated, using commercial LC-MS instrumentation and
software. By utilizing the narrow bore 10 mm ID PLOT columns,
high sensitivity is achieved, which is important for detecting
proteins present at low concentrations in samples of limited
availability. The system performance is demonstrated by detecting
targeted Wnt-pathway proteins from cell lines and xenograft
tissues.
Materials and Methods
Chemicals, reagents and materials
All chemicals, reagents and materials were obtained from
commercial sources and chemicals/reagents were of analytical
grade. See Chemicals, reagents and materials S1 in File S1, for
more details.
OTER preparation
For a visual description of the production of the OTERs, see
Video S1. Figure S1 in File S1 illustrates the reaction chemistry of
the OTER. In short; the wall-polymerization solution consisting of
0.08 g HEMA, 0.02 g VDM, 0.60 g 1-heptanol and 0.0001 g
AIBN, was filled into a 20 mm ID pre-treated fused silica capillary
using an in-house made pressure bomb, and the capillary ends
were sealed by sticking the ends into septa (originally intended for
use in gas chromatography (GC) injection systems). The polymer-
ization was performed in an oven (originally intended for GC
column heating) at 65uC for 5 hours, followed by 80uC for
5 hours. The polymerized capillary was dried with nitrogen for
30 min. Immobilization was performed by flushing the column
with the appropriate enzyme solution (trypsin: 2.5 mg/mL trypsin
and 0.25 mg/mL benzamidine, Lys-C; 5–15 mg/mL Lys-C and
0.5–1.5 mg/mL benzamidine, Trypsin/Lys-C mix; 20 mg/
mLTrypsin/Lys-C and 0.2 mg/mL benzamidine, solved in
20 mM phosphate buffer, pH 7.4) for 3 hours. The OTER was
subsequently filled with 50 mM ammonium acetate, pH 6–7 and
stored at 4uC.
For detailed description of production of the pre-columns and
polystyrene divinylbenzene (PS-DVB) PLOT LC columns (previ-
ously described in [37]) see Methods S1 in File S1.
Figure 2. SEM image of the OTER (20 mm ID) (the immobilized
enzymes are too small to be visualized in the image). The
polymeric layer was ,0.4 mm (dry).
doi:10.1371/journal.pone.0106881.g002
Figure 1. System set-up using an Easy-nLC1000 pump
equipped with two extra standard 6-port valves (V1 and V2).
See Animation S1 for more detailed valve position during the platform
performance. The OTER is kept in a column oven at 37uC.
doi:10.1371/journal.pone.0106881.g001
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OTER-PLOT system set-up
The manual OTER-PLOT system is described in detail
elsewhere [37] and in Methods S2 File S1. For the automated
set-up (see Figure 1 and Animation S1) an Easy nLC1000
(Thermo Fisher Scientific, Bremen, Germany) pump was used
for injection, column equilibration and gradient elution. Mobile
phase A (MP A) contained 4% ACN in 0.1% FA, whereas MP B
contained 0.1% FA in ACN. To incorporate the enzymatic reactor
to the Easy nLC1000 pump, two automatic port switching valves
were added; one Rheodyne 6-port valve (V1, Figure 1, IDEX
Health & Science LLC, Rohnert Park, CA, USA) and one 10-port
valve (V2, shown as a 6-port in Figure 1, VICI, Valco Instruments
Co. Inc., Houston, TX, USA), both connected to the MS contact
closure outputs and controlled by the MS instrument software.
Note that valve V2 may be replaced with a 6-port valve and is
illustrated as such for simplicity. Fused silica tubing (20 mm ID)
was used between valves S, V1 and V2.
Five mL sample were loaded onto the injection loop, and an
appropriate volume was loaded onto the OTER (4 meter
(,1.2 mL) connected using PicoClear unions (New Objective,
Woburn, MA, USA)) at a flow rate of 0.5 mL/min (V1 with
connecting ports 1 and 2 and V2 connecting ports 1 and 6). The
OTER was conveniently placed inside a column oven (Mistral,
Spark Holland) at 37uC. After loading, V1 was switched;
connecting ports 1 and 6 and the tubing was flushed for 5
minutes with 100% MP A while the autosampler loop was flushed
with 4% ACN in 50 mM ammonium acetate. V2 was switched,
connecting ports 1 and 6 and the pre-column and PLOT column
were equilibrated for 55 minutes at 40 nL/min. 2 mL 4% ACN in
50 mM ammonium acetate eluted the generated peptides from the
OTER and onto the 50 mm ID x 4 cm butyl-methacrylate (BuMa)
monolithic pre-column, with valve W connecting ports 1 and 2, for
4 minutes at 0.5 mL/min. The pre-column was used to trap and
desalt the peptides. The flow was split to 40 nL/min by switching
valve W to connect ports 1 and 6, and peptides were separated
using a linear gradient from 0–40% MP B in 40 minutes, with a
subsequent linear step up to 95% MP B in 10 minutes and kept at
95% MP B for 10 minutes, on a 10 mm ID x 500 cm long PS-
DVB-PLOT column.
For analysis of pre-digested samples, valves V1 and V2 were set
in the position connecting ports 1 and 6, and ports 1 and 2,
respectively, and 1 mL sample was loaded onto the pre-column for
4 minutes at a flow-rate of 0.5 mL/min, with subsequent
separation of peptides on the PS-DVB PLOT column.
For the comprehensive set-up, gradient elution was performed
from 0–40% MP B in 250 minutes, with a linear increase to 95%
MP B in 10 minutes and wash at 95% MP B for 20 minutes. For
targeted investigations, linear gradient elution was performed for
40 minutes from 0–40% MP B, with a linear increase for 10
minutes to 95% MP B and a hold at 95% MP B for 10 minutes.
The PLOT column was connected to a Q-Exactive Mass
Spectrometer (Thermo Fisher Scientific) equipped with a 10 mm
ID to 561 mm nanospray ESI-emitter (PicoTip, New Objective),
with an applied voltage of 1.3 kV and capillary temperature of
250uC. The system could just as easily be connected to other mass
spectrometers. e.g. a triple quadrupole MS for quantitative
multiple reaction monitoring (MRM).
Mass spectrometry
For data-dependent acquisition the full MS scan range was set
to m/z 350–1850 and the 12 most intense ions were selected for
fragmentation. The full MS resolution was 70,000 with an
automatic gain control (AGC) target value of 1e6 and maximum
fill time of 120 ms. The MS/MS resolution was set to 35,000 with
AGC target value of 1e5 and maximum fill time of 120 ms. The
ions were fragmented with a normalized collision energy (NCE) of
25, isolation width of m/z 2.0 and only ions with charge +2 - +6
were selected for fragmentation. The dynamic exclusion was set to
30 seconds. The Easy nLC1000 and Q-Exactive Orbitrap were
controlled by Xcalibur software (v2.2, Thermo Fisher Scientific).
For preparation of the standard solutions, HCT15 cell lysate,
tumor tissue and database search, see Methods S3 and S4 in File
S1. A list of identified proteins can be found in Table S1. Other
raw files and spreadsheets are available at http://www.mn.uio.no/
kjemi/supplementary-data/bach/Open-tubular-lab-on-column-mass-
spectrometry-for-targe/. In the unexpected event of web relocation
of the raw data files, we will provide the new web address in the
comments section of the online version of this paper.
Ethics statement
The tumor tissue samples were from 6 week old female CB17
SCID mice xenografted with HCT15 cells that were treated with
tankyrase inhibitor G007-LK, which was administered at 10 mg/
kg daily (study described in Lau et al [38]). All animal experiments
were approved by the Norwegian Animal Research Authority
(NARA) and were carried out following accepted ethical
standards. The experiments/procedures have thus been conducted
in accordance with the laws and regulations controlling experi-
ments/procedures of live animals in Norway, i.e. the Animal
Welfare Act of December 20th 1974, No 73, chapter VI sections
20–22 and the Regulation on Animal Experimentation of January
15th 1996. In addition, Norway has signed and ratified The
European Convention for the protection of Vertebrate Animals
used for Experimental and other Scientific Purposes of March
18th 1986. The Norwegian legislation conforms in all respects with
the basic requirements of this Convention and guidelines prepared
in pursuance of it. All efforts were made to minimize the number
and suffering of animals.
For details regarding the preparation of these samples, see
Methods S3.4 in File S1.
Results and Discussion
In order to further develop the prototype OTER-PLOT-LC-
MS [37] into an applicable platform, several improvements were
needed regarding the OTER and automation of the platform.
Figure 3. Repeatability of performance (defined as number of
identified proteins and SQ%) of three individually produced
OTERs. A 10 protein standard mix (equal molarity of each protein) was
digested in the automated platform, OTER volume was ,300 nL and
three replicate injections were performed for each OTER.
doi:10.1371/journal.pone.0106881.g003
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OTER features and characteristics
In a narrow bore open format, open tubular enzyme reactors
(OTERs) have been found to be easy to repeatedly prepare and
with less backpressure (and thus short preparation times when
filling reagents into capillaries with the pressure bomb) compared
to monolithic and packed reactors [39–43]. To increase the
effective surface area compared to previous efforts ([37]), longer
reactors need to be used [44]. Increasing the reactor volume also
allows for exploiting more of the available small sample. Changing
the porogenic solvent in the polymerization solution from 1-
decanol (used in [37] based on procedures described in reference
[45]) to 1-heptanol, reactors of 1 meter (,300 nL volume) were
easily produced. A scanning electron microscope (SEM) image of
the inside of an OTER can be seen in Figure 2; a thin polymeric
layer of ,0.4 mm (dry) with evenly spread globules make up the
anchoring phase for the proteolytic enzymes.
Figure 4. Graphical overview of the OTER-PLOT nanoproteomic platform.
doi:10.1371/journal.pone.0106881.g004
Figure 5. Extracted ion chromatograms of 5 chosen peptides from the 10 protein standard mix. The average peak width at 10% peak
height (W0.1) was ,6 seconds.
doi:10.1371/journal.pone.0106881.g005
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Trypsin is the most used proteolytic enzyme for the conversion
of proteins to peptides, also in micro scale IMERs. Only a few
IMERs are reported immobilized with other enzymes such as Lys-
C, pepsin, PNGase F, proteinase K and chymotrypsin [30,44].
Choosing a combination of trypsin and Lys-C, which is often used
in off-line digestion can provide a more complete digestion of
proteins by reducing the number of missed cleavage sites, enabling
improved repeatability and accuracy [46]. In initial investigations
of reactor performance Lys-C, trypsin and Trypsin/Lys-C mix,
were immobilized onto short 20 mm ID (,60 nL) polymerized
reactors and observed digestion of a standard protein, cytochrome
C (commonly used to evaluate IMERs) was used for measuring
reactor efficiency. The Trypsin/Lys-C reactor gave a 30%
increase in cleaved protein, outperforming the Lys-C-only and
trypsin-only immobilized reactors. With a reactor volume of
,60 nL, only 2 out of 10 proteins in a standard mix were digested,
but by increasing the length (and hence the volume) of the reactor
5-fold (,300 nL), 10 out of the 10 proteins could be identified
(Figure 3). A reactor digestion temperature of 50uC resulted in
higher sequence coverage and more identified standard proteins
compared to 22 and 37uC (Figure S2 in File S1). However, a
reactor temperature of 50uC was associated with poor perfor-
mance (less identified proteins) when longer (up to 2 h) digestion
times were evaluated (Figure S3 in File S1), thus digestion at 37uC
was chosen as it provided far more robust performance. As a
compromise between time and throughput, 1 hour digestion time
was chosen for the on-line analysis of the cell lysate and tumor
xenograft samples. The reactors showed good repeatability of
performance when three 1 meter (,300 nL) individually prepared
OTERs were used for digestion of the 10 protein standard mix
(Figure 3).
The complementary combination of trypsin and Lys-C has, as
already mentioned, been investigated in several off-line experi-
ments, but to the authors’ knowledge for the first time been
exploited in the open tubular IMER format with a reactor volume
that makes them very suitable for analysis of small samples.
A fully automated nanoproteomic platform
Automated systems are usually required for high-throughput
analysis. On-line protein digestion (with integrated OTER) and
subsequent peptide separation (PLOT column) was performed
with a fully automated platform using a commercial nLC system,
with minimum dead volumes and low backpressures (,400 bar).
A schematic overview of the platform is presented in Figure 4.
Figure 1 (and Animation S1) provides a detailed description of the
plumbing and valve positions of the platform.
Although other sensitive nanoflow columns in somewhat larger
formats exists, e.g. 25 mm ID packed columns for peptide
separations [47], PLOT LC columns are associated with good
column-to-column production repeatability together with high
performance and little carry-over [31,34] and are well adapted to
be coupled on-line to enzyme reactors [37].
Figure 5 shows that chromatographic peaks can be very narrow
using the automated OTER-PLOT platform (typical peak widths
W0.1 are ,6 seconds). Conveniently, the system set-up can be
Figure 6. A. EIC of identified peptide TSVQPSHLFIQDPTMPPHPAPNPLTQLEEAR corresponding to Axin1 in standard mixture,
HCT15 cell protein extract digested off-line and on-line. B. EIC of identified peptide HETGSHDAER corresponding to APC in protein extracts
from HCT15 cell line and HCT15 xenograft, respectively. OTER volume was approximately 1.2 mL.
doi:10.1371/journal.pone.0106881.g006
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programmed to perform both conventional LC-MS (i.e. analysis of
pre-digested samples) and OTER-PLOT performance, without
any hardware changes. Figure 6 A and B show that peak shapes,
retention times and peak widths obtained in traditional off-line
digestion mode and OTER-PLOT mode are very similar
(evaluated with signature peptides that were easily produced with
both in-solution digestion and OTER), which is a testament to the
robustness of the automated OTER-PLOT platform.
The OTER-PLOT run time including both protein digestion
and LC-MS processing was typically 240 min (1 h digestion,
150 min LC run time) in comprehensive mode and 120 min (1 h
digestion and 60 min LC run time) in targeted mode (which is our
current main focus). However, these run times can be shorted and
lengthened for faster analysis or higher peak capacities, respec-
tively. All samples analysed in the platform were reduced and
alkylated in advance, but as Kim et al. suggest this step might be
avoided due to the enhanced rate of proteolysis that is provided by
IMERs, that in many cases allows direct digestion of proteins
without reduction and alkylation.
The platform carry-over was generally not detectable (Figure 7),
but it should be mentioned that in rare cases up to 2.5% carry-
over could be observed for certain peptides, when injecting very
high concentrations of standard protein mix (300 mg/mL).
The platform, being automated and consisting of both
integrated protein digestion and chromatographic separation in
narrow open tubular columns is unique in its field today. Others
have described related set-ups (using larger bore packed/
monolithic columns), but none with e.g. a fully integrated IMER
and simple commercial instrumentation. Kim et al. describe a
semi-automatic system for reducing digestion time [48], but the
IMER was not connected to the LC-MS system due to
reproducibility considerations. Sproß et al. describe a fully
Figure 7. Carry-over of the highest abundant peptide ions in a blank following injection of a 10 protein standard mix. Upper
chromatogram: TIC of the standard protein mixture, lower chromatograms; zoom-in of three of the highest abundant ions in the standard protein
mix compared to the same ions in the blank (not able to extract). OTER volume was approximately 1.2 mL.
doi:10.1371/journal.pone.0106881.g007
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automated on-line 3D nano-HPLC/nano-ESI-Q-TOF-MS/MS
system composed of a monolithic trypsin reactor in the first
dimension, a monolithic affinity column in the second dimension,
and C18 HPLC-Chip in the third dimension [49], requiring 4
high performance pumps. In contrast, the OTER-PLOT platform
requires only one nanoLC pump with two additional valves that
are easily controlled by the MS software.
Platform demonstration
Targeted proteomics. To consider the potential of OTER-
PLOT for targeting diagnostic markers, the system must feature
high sensitivity and selectivity for the targets in complex samples.
In this context, Axin1 and adenomatous polyposis coli (APC) were
monitored in biological samples by the OTER-PLOT set-up;
Axin1 (96 kDa) and APC (311 kDa) are low abundant, house-
keeping proteins of the Wnt-pathway, regulating proteasomal
degradation of b-catenin [50,51]. Several studies have shown that
mutations/alterations in either of these two proteins can lead to
development of colorectal cancer [52]. Additionally, the levels of
both Axin1 and APC have been reported as potential markers for
colorectal cancer [53–57].
Using high resolution Orbitrap-MS (well suited to selectively
target low abundant peptides in the presence of a complex
background [58]) with the OTER-PLOT platform, Axin1 was
detected in a colon cancer cell (HCT15) lysate within two hours
per sample (Figure 6A), with protein identification supported by
matching retention time/mass spectra with an external standard.
The retention time of the proteotypic Axin1 peptide varied less
than 4% between the standard and the complex sample.
Combined with the fragmentation mass spectra (Figure S4 A in
File S1) the selectivity of this automated assay is high.
Similarly, the platform can be used to detect target proteins in
tumor samples, identifying APC in an HCT15 based-tumor
(mouse xenograft model) as well as its parent cell line; Figure 6B
shows the extracted ion chromatogram (EIC) of a proteotypic
peptide from a total protein extract prepared from HCT15
originating tumor tissue and HCT15 cells, using the OTER-
PLOT platform. In the present study tumor sample of 500 ng
(protein extract) was used for analysis and sufficient to detect APC.
Importantly, the OTER-PLOT assay is not susceptible to the mass
limitations in WB or antibody selectivity issues, as has been
demonstrated for APC.
Very narrow open tubular columns should be particularly well
suited for handling limited samples; Indeed, the target protein
Axin1 could be unambiguously detected (with target peptides
easily produced when using OTER) when introducing just 10 ng
of sample to the OTER (corresponding to HCT15 cell protein
extract from ,1,000 cells, see experimental section and Methods
S3.3 in File S1) (Figure 8), demonstrating the high sensitivity and
small sample capability of the platform.
Although the platform was found to have low carry-over, blank
injections were routinely performed and evaluated before sample
injections.
Comprehensive proteomics. Even though our primarily
goal was to use the OTER-PLOT platform for targeted
determinations, it could also be applied for comprehensive
analysis. In a single run using a relatively short gradient program
(150 min), 1462 proteins were identified in a protein extract
(500 ng total protein extract) from HCT15 cells with high peptide
confidence, FDR: 0.01 (Figure 9; see also http://www.mn.uio.no/
kjemi/supplementary-data/bach/Open-tubular-lab-on-column-mass-
spectrometry-for-targe/for raw files and Table S1 for list of identified
proteins).
This is a significant improvement compared to similar
approaches with integrated IMERs [44] reporting between 78
and 541 proteins identified from much higher amounts of sample
digested on-line (e.g. 2.0–2.4 mg [59,60]); Sun et al reported ,220
protein IDs when working with similar protein amounts,
employing off-line immobilized trypsin digestion [61]. Other
central Wnt-pathway proteins were readily identified in the
comprehensive mode; such as b-catenin, low density lipoprotein
receptor-related protein 6 (LRP5/6), disheveled segment polarity
protein 1 (DVL), and casein kinase 2 (CK2), showing that
untargeted OTER-PLOT can provide useful complementary
information within reasonable time.
Conclusion
A fully automated open tubular-based nanoproteomic platform,
utilizing commercially available instrumentation and equipment,
has successfully been developed for sensitive on-line digestion/
detection of targeted proteins in biological samples of limited sizes
(e.g. ,1,000 cells). With this workflow, low abundant targets can
Figure 8. EIC of identified peptide cVDMGcAGLR correspond-
ing to Axin1 in off-line digested standard mixture, 500, 100
and 10 ng HCT15 cell protein extract digested on-line in the
nanoproteomic platform. OTER volume was approximately 1.2 mL.
doi:10.1371/journal.pone.0106881.g008
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be monitored in a few hours from sample collection to data
analysis. Although, the novel OTER-PLOT platform already
performs at a high level, we expect it to have even higher output/
selectivity following further optimizations (regarding e.g. column
polymer chemistry, column dimensions, affinity column add-ons
etc.).
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File S1 Chemicals, reagents and materials, methods
and supporting figures. Chemicals, reagents and mate-
rials S1. Figure S1, Reaction chemistry of the OTER:
Polymerization and subsequent immobilization of en-
zyme through the azlactone functionalities of VDM. R=
Trypsin/Lys-C. Figure S2, Sequence coverage (%) of the 10
protein standard mix with digestion at 226C, 376C, 506C
and with temperature gradient from 22–506C in 30
minutes. Figure S3, Sequence coverage (%) as function
of digestion time at 506C (5 min, 15 min, 30 min, 1 h
and 2 h). Figure S4, A, Axin1 fragment spectra for
peptide TSVQPSHLFIQDPTMPPHPAPNPLTQLEEAR in
standard, off-line digest and on-line digest. B, APC
fragment spectra for peptide HETGSHDAER in protein extracts
from HCT15 cell line and HCT15 xenograft, respectively. Figure
S5, Manual system used in the development of the
platform. Methods S1, Preparation of PLOT and
monolithic capillary columns. Methods S2, The nano-
proteomic platform, manual system. Methods S3,
Standard solutions and sample preparations. Methods
S4, Database search.
(DOCX)
Table S1 List of identified proteins in comprehensive
proteomics experiment.
(XLSX)
Animation S1 Operation of automated OTER-PLOT
platform.
(MOV)
Video S1 Step-by-step production of open tubular
enzymatic reactor (OTER).
(MOV)
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